Mathew Esona

Dr. Mathew Esona

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2009 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MEMathew Esona
Mathew Esona
AGA. Geyer
A. Geyer
NPNicola Page
Nicola Page
ATA. Trabelsi
A. Trabelsi
IFI. Fodha
I. Fodha
JGJ.R. Gentsch
J.R. Gentsch


16 December 2013 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
PDF file
RGRashi Gautam
Rashi Gautam
MEMathew Esona
Mathew Esona
SRSlavica Mijatovic Rustempasic
Slavica Mijatovic Rustempasic
KTKa Ian Tam
Ka Ian Tam
JGJon R Gentsch
Jon R Gentsch
MBMichael D Bowen
Michael D Bowen
Group A rotaviruses (RVA) are the leading cause of severe diarrhea in young children worldwide. Two live-attenuated RVA vaccines, Rotarix® and RotaTeq® are recommended by World Health Organization (WHO) for routine immunization of all infants. Rotarix® and RotaTeq® vaccines have substantially reduced RVA associated mortality but occasionally have been associated with acute gastroenteritis (AGE) cases identified in vaccinees and their contacts. High-throughput assays are needed to monitor the prevalence of vaccine strains in AGE cases and emergence of new vaccine-derived strains following RVA vaccine introduction. In this study, we have developed quantitative real-time RT-PCR (qRT-PCR) assays for detection of Rotarix® and RotaTeq® vaccine components in stool samples. Real-time RT-PCR assays were designed for vaccine specific targets in the genomes of Rotarix® (NSP2, VP4) and RotaTeq® (VP6, VP3-WC3, VP3-human) and validated on sequence confirmed stool samples containing vaccine strains, wild-type RVA strains, and RVA-negative stools. For quantification, standard curves were generated using dsRNA transcripts derived from RVA gene segments. Rotarix® NSP2 and VP4 qRT-PCR assays exhibited 92–100% sensitivity, 99–100% specificity, 94–105% efficiency, and a limit of detection of 2–3 copies per reaction. RotaTeq® VP6, VP3-WC3, and VP3-human qRT-PCR assays displayed 100% sensitivity, 94–100% specificity, 91–102% efficiency and limits of detection of 1 copy, 2 copies, and 140 copies, respectively. These assays permit rapid identification of Rotarix® and RotaTeq® vaccine components in stool samples from clinical and surveillance studies and will be helpful in determining the frequency of vaccine strain-associated AGE.

1 January 2009 in Emerging Infectious Diseases
Verified
Journal Article
Open access
MEMathew Esona
Mathew Esona
AGAnnelise Geyer
Annelise Geyer
Krisztian BanyaiKrisztian Banyai
Krisztian Banyai
NPNicola Page
Nicola Page
MAMaryam Aminu
Maryam Aminu
JGJon R. Gentsch
Jon R. Gentsch
We report characterization of a genotype G5P[7] human rotavirus (HRV) from a child in Cameroon who had diarrhea. Sequencing of all 11 gene segments showed similarities to >5 genes each from porcine and human rotaviruses. This G5P[7] strain exemplifies the importance of heterologous animal rotaviruses in generating HRV genetic diversity through reassortment.

1 October 2015 in Journal of Virological Methods
Verified
Journal Article
Closed access
MEMathew Esona
Mathew Esona
RGRashi Gautam
Rashi Gautam
KTKa Ian Tam
Ka Ian Tam
AWAlice Williams
Alice Williams
SMSlavica Mijatovic-Rustempasic
Slavica Mijatovic-Rustempasic
MBMichael D. Bowen
Michael D. Bowen

1 September 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MEMathew Esona
Mathew Esona
DSDuncan Steele
Duncan Steele
TKTara Kerin
Tara Kerin
GAGeorge Armah
George Armah
IPIna Peenze
Ina Peenze
JGJon Gentsch
Jon Gentsch
A total of 215 nontypeable rotavirus samples collected from children <5 years of age by members of the African Rotavirus Network were characterize